These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7026742)

  • 1. Non-essential role of dietary factors in the development of diabetes in ob/ob mice.
    Dubuc PU
    J Nutr; 1981 Oct; 111(10):1742-8. PubMed ID: 7026742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.
    Dubuc PU; Cahn PJ; Willis P
    Int J Obes; 1984; 8(3):271-8. PubMed ID: 6378818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food restriction normalizes somatic growth and diabetes in adrenalectomized ob/ob mice.
    Dubuc PU; Carlisle HJ
    Am J Physiol; 1988 Nov; 255(5 Pt 2):R787-93. PubMed ID: 3056042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal function and the effect of a high-fat diet on C57BL/6J and C57BL/6J-ob/ob mice.
    Herberg L; Kley HK
    Horm Metab Res; 1975 Sep; 7(5):410-5. PubMed ID: 1183921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starvation and age effects on glycoregulation and hormone levels of C57BL/6Job/ob mice.
    Dubuc PU; Cahn PJ; Ristimaki S; Willis PL
    Horm Metab Res; 1982 Oct; 14(10):532-5. PubMed ID: 6757086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
    Irwin N; Montgomery IA; Moffett RC; Flatt PR
    Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
    O'Harte FP; Franklin ZJ; Irwin N
    Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.
    Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB
    Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance in aging obese (ob/ob) and lean mice.
    Dubuc PU; Ristimaki S; Cahn PJ; Willis PL
    Horm Metab Res; 1983 Mar; 15(3):120-3. PubMed ID: 6343213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adrenalectomy on energy balance of obese mice are diet dependent.
    Smith CK; Romsos DR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R13-22. PubMed ID: 3893165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced acute response to corticosterone in genetically obese (ob/ob) mice.
    Tokuyama K; Himms-Hagen J
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E133-8. PubMed ID: 2669510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations.
    Alberts P; Rönquist-Nii Y; Larsson C; Klingström G; Engblom L; Edling N; Lidell V; Berg I; Edlund PO; Ashkzari M; Sahaf N; Norling S; Berggren V; Bergdahl K; Forsgren M; Abrahmsén L
    Horm Metab Res; 2005 Jul; 37(7):402-7. PubMed ID: 16034710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice.
    Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML
    Endocrinology; 2004 Jul; 145(7):3258-64. PubMed ID: 15059949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of the genetically obese mouse to corticosterone.
    Tokuyama K; Himms-Hagen J
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E202-8. PubMed ID: 3548420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
    Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
    Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
    Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
    J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient postweaning expression of excessive fat deposition and diabetes mellitus in ob/ob mice.
    Dubuc PU
    Growth Dev Aging; 1996; 60(3-4):145-51. PubMed ID: 9007565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.